+
Open data
-
Basic information
| Entry | Database: PDB / ID: 9yel | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Title | Human muscle nAChR SCCMS eL269F ACh, Fluoxetine bound | |||||||||||||||||||||
Components | (Acetylcholine receptor subunit ...) x 4 | |||||||||||||||||||||
Keywords | MEMBRANE PROTEIN / human muscle / nicotinic acetylcholine receptor | |||||||||||||||||||||
| Function / homology | Function and homology informationpostsynaptic membrane organization / musculoskeletal movement / skeletal muscle tissue growth / Highly sodium permeable postsynaptic acetylcholine nicotinic receptors / Highly calcium permeable nicotinic acetylcholine receptors / neuromuscular synaptic transmission / Highly calcium permeable postsynaptic nicotinic acetylcholine receptors / acetylcholine receptor activity / acetylcholine-gated channel complex / behavioral response to nicotine ...postsynaptic membrane organization / musculoskeletal movement / skeletal muscle tissue growth / Highly sodium permeable postsynaptic acetylcholine nicotinic receptors / Highly calcium permeable nicotinic acetylcholine receptors / neuromuscular synaptic transmission / Highly calcium permeable postsynaptic nicotinic acetylcholine receptors / acetylcholine receptor activity / acetylcholine-gated channel complex / behavioral response to nicotine / acetylcholine-gated monoatomic cation-selective channel activity / muscle cell development / acetylcholine receptor signaling pathway / muscle cell cellular homeostasis / monoatomic cation transmembrane transporter activity / acetylcholine binding / neuromuscular process / nervous system process / neuron cellular homeostasis / postsynaptic specialization membrane / synaptic transmission, cholinergic / neuromuscular junction development / membrane depolarization / monoatomic cation transport / ligand-gated monoatomic ion channel activity / neuronal action potential / skeletal muscle contraction / muscle contraction / presynaptic modulation of chemical synaptic transmission / response to nicotine / neuromuscular junction / transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential / regulation of membrane potential / transmembrane signaling receptor activity / presynapse / channel activity / chemical synaptic transmission / monoatomic ion transmembrane transport / postsynaptic membrane / neuron projection / synapse / cell surface / signal transduction / plasma membrane Similarity search - Function | |||||||||||||||||||||
| Biological species | Homo sapiens (human) | |||||||||||||||||||||
| Method | ELECTRON MICROSCOPY / single particle reconstruction / cryo EM / Resolution: 2.48 Å | |||||||||||||||||||||
Authors | Li, H. / Hibbs, R.E. | |||||||||||||||||||||
| Funding support | United States, 1items
| |||||||||||||||||||||
Citation | Journal: Nature / Year: 2026Title: Correcting congenital myasthenia-associated acetylcholine receptor defects. Authors: Huanhuan Li / Nuriya Mukhtasimova / Jinfeng Teng / Elfie S Cavalli / Xilin Gu / Jason K Sello / Steven M Sine / Ryan E Hibbs / ![]() Abstract: Voluntary muscle contraction is triggered by the neurotransmitter acetylcholine binding its receptors on the postsynaptic membrane of the neuromuscular junction, opening ion channels that allow ...Voluntary muscle contraction is triggered by the neurotransmitter acetylcholine binding its receptors on the postsynaptic membrane of the neuromuscular junction, opening ion channels that allow cation influx and initiate depolarization. Mutations in muscle acetylcholine receptors disrupt this process by either impairing (fast-channel) or prolonging (slow-channel) channel openings. These defects cause congenital myasthenic syndromes (CMS), characterized by severe muscle weakness that is often present at birth and, in some cases, progresses to paralysis and death. The structural mechanisms underlying these pathogenic defects and their pharmacological correction remain unknown. Here, using cryogenic electron microscopy, chemical biology and electrophysiology, we determined the structures and functional consequences of representative CMS mutant receptors with and without drugs. In fast-channel disease-associated mutants, we discovered a cryptic allosteric site targeted by positive modulators that restore gating in a mutation-specific manner. In receptor mutants associated with slow-channel disease, quinidine, fluoxetine and reboxetine act as pore blockers; notably, the antidepressant reboxetine selectively blocks desensitized receptors in a mutation-independent fashion, suggesting repurposing potential. Mechanistically, fast-channel mutations uncouple agonist binding from gating, whereas slow-channel mutations stabilize an abnormally widened, desensitized-like pore. These findings reveal unifying principles of CMS pathogenesis and provide a framework for precision therapies. | |||||||||||||||||||||
| History |
|
-
Structure visualization
| Structure viewer | Molecule: Molmil Jmol/JSmol |
|---|
-
Downloads & links
-
Download
| PDBx/mmCIF format | 9yel.cif.gz | 751.1 KB | Display | PDBx/mmCIF format |
|---|---|---|---|---|
| PDB format | pdb9yel.ent.gz | 636.3 KB | Display | PDB format |
| PDBx/mmJSON format | 9yel.json.gz | Tree view | PDBx/mmJSON format | |
| Others | Other downloads |
-Validation report
| Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/ye/9yel ftp://data.pdbj.org/pub/pdb/validation_reports/ye/9yel | HTTPS FTP |
|---|
-Related structure data
| Related structure data | ![]() 72854MC ![]() 9ye6C ![]() 9ye7C ![]() 9ye8C ![]() 9yehC ![]() 9yeiC ![]() 9yekC ![]() 9yerC ![]() 9yetC ![]() 9yeuC ![]() 9yexC ![]() 9yf0C M: map data used to model this data C: citing same article ( |
|---|---|
| Similar structure data | Similarity search - Function & homology F&H Search |
-
Links
-
Assembly
| Deposited unit | ![]()
|
|---|---|
| 1 |
|
-
Components
-Acetylcholine receptor subunit ... , 4 types, 5 molecules ACEDB
| #1: Protein | Mass: 49747.645 Da / Num. of mol.: 2 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Gene: CHRNA1, ACHRA, CHNRA / Production host: Homo sapiens (human) / References: UniProt: P02708#2: Protein | | Mass: 54840.750 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Gene: CHRNB1, ACHRB, CHRNB / Production host: Homo sapiens (human) / References: UniProt: P11230#3: Protein | | Mass: 56915.359 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Gene: CHRND, ACHRD / Production host: Homo sapiens (human) / References: UniProt: Q07001#4: Protein | | Mass: 52817.309 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Source: (gene. exp.) Homo sapiens (human) / Gene: CHRNE, ACHRE / Production host: Homo sapiens (human) / References: UniProt: Q04844 |
|---|
-Sugars , 3 types, 6 molecules 
| #5: Polysaccharide | Source method: isolated from a genetically manipulated source #6: Polysaccharide | Source method: isolated from a genetically manipulated source #9: Sugar | ChemComp-NAG / | |
|---|
-Non-polymers , 3 types, 5 molecules 




| #7: Chemical | | #8: Chemical | ChemComp-RFX / ( | #10: Water | ChemComp-HOH / | |
|---|
-Details
| Has ligand of interest | Y |
|---|---|
| Has protein modification | Y |
-Experimental details
-Experiment
| Experiment | Method: ELECTRON MICROSCOPY |
|---|---|
| EM experiment | Aggregation state: PARTICLE / 3D reconstruction method: single particle reconstruction |
-
Sample preparation
| Component | Name: Human muscle nicotinic acetylcholine receptor CMS mutants Type: COMPLEX / Entity ID: #1-#4 / Source: RECOMBINANT |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
| Source (recombinant) | Organism: Homo sapiens (human) |
| Buffer solution | pH: 7.4 |
| Specimen | Embedding applied: NO / Shadowing applied: NO / Staining applied: NO / Vitrification applied: YES |
| Vitrification | Cryogen name: ETHANE |
-
Electron microscopy imaging
| Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
|---|---|
| Microscopy | Model: TFS KRIOS |
| Electron gun | Electron source: FIELD EMISSION GUN / Accelerating voltage: 300 kV / Illumination mode: OTHER |
| Electron lens | Mode: BRIGHT FIELD / Nominal defocus max: 1800 nm / Nominal defocus min: 1000 nm |
| Image recording | Electron dose: 50 e/Å2 / Film or detector model: FEI FALCON III (4k x 4k) |
-
Processing
| EM software |
| ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CTF correction | Type: PHASE FLIPPING AND AMPLITUDE CORRECTION | ||||||||||||||||||||||||
| 3D reconstruction | Resolution: 2.48 Å / Resolution method: FSC 0.143 CUT-OFF / Num. of particles: 211224 / Algorithm: FOURIER SPACE / Symmetry type: POINT | ||||||||||||||||||||||||
| Refinement | Highest resolution: 2.48 Å Stereochemistry target values: REAL-SPACE (WEIGHTED MAP SUM AT ATOM CENTERS) | ||||||||||||||||||||||||
| Refine LS restraints |
|
Movie
Controller
About Yorodumi




Homo sapiens (human)
United States, 1items
Citation






















PDBj




FIELD EMISSION GUN